Periocular sebaceous carcinoma: updates in the diagnosis, treatment, staging, and management
International Journal of Dermatology · 2024
DOI: 10.1111/ijd.17045 ↗At a glance
Übersichtsarbeit in International Journal of Dermatology, 2024. Written by Federica Dini and 10 co-authors. Institution: Department of Neurosciences, Psychology, Drug Research and Child Health Eye Clinic, University of Florence, Florence, Italy. Major MEDLINE topics: Sebaceous Gland Neoplasms, Eyelid Neoplasms, Adenocarcinoma, Sebaceous, Neoplasm Staging. Cited 14 times so far (Crossref); 50 references.
Abstract (original language)
Periocular sebaceous carcinoma (PSC) is a rare, aggressive, and potentially metastatic adnexal malignancy. Due to the ability of PSC to resemble several benign and malignant conditions, diagnosis is often delayed or mistaken. In addition, even with a known diagnosis, choosing the right treatment is still an open debate. For this reason, we decided to review the most up‐to‐date literature on PSC and propose a dedicated procedural protocol to help clinicians when dealing with PSC. A PubMed search was carried out using the terms “Sebaceous Carcinoma”, “Adnexal Periocular Cancer”, “Sebaceous Carcinoma AND eyelid”, “Periocular Sebaceous Carcinoma”, and “Ocular Adnexa”. Pertinent studies published in English from 1997 up to December 2022 were compared to the selection criteria and if suitable, included in this review. Through the initial search, 84 articles were selected. Of these, 36 were included in the final study. Several papers explored different diagnostic and therapeutic strategies regarding PSC diagnosis and management. In light of the current literature review and the multidisciplinary experience of three clinical centers, a dedicated procedural protocol is proposed. PSC diagnosis may be achieved through accurate clinical evaluation, but it requires histopathologic confirmation, which can be challenging. Dermoscopy, in vivo reflectance confocal microscopy, and optical coherence tomography may facilitate PSC clinical examination, while immunohistochemistry stains may support histological diagnosis. Appropriate disease staging is necessary before choosing the treatment, as local disease requires radically different treatment compared to advanced disease. In addition, recent innovations in nonsurgical treatments, including radio‐chemotherapy, immunotherapy, and targeted therapy, may be a viable option in the most challenging cases.
Subjects
MeSH terms (MEDLINE)
Authors and institutions
- Department of Neurosciences, Psychology, Drug Research and Child Health Eye Clinic, University of Florence, Florence, Italy.
- Plastic Surgery Unit, Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy.
- Section of Anatomic Pathology, Department of Health Sciences, University of Florence, Florence, Italy.
- Plastic and Reconstructive Microsurgery, Careggi University Hospital, Florence, Italy.
- Clinical Oncology Unit, University Hospital Careggi, Florence, Italy.
- Unit of Ocular Oncology, Neuromuscular and Sense Organs Department, Careggi University Hospital, Florence, Italy.
ORCID profiles: Vincenzo De Giorgi
Cite
APA
Dini, F., Susini, P., Nisi, G., Cuomo, R., Grimaldi, L., Massi, D., Innocenti, A., Doni, L., Mazzini, C., Santoro, N., & De Giorgi, V. (2024). Periocular sebaceous carcinoma: updates in the diagnosis, treatment, staging, and management. International Journal of Dermatology. https://doi.org/10.1111/ijd.17045
Vancouver
Dini F, Susini P, Nisi G, Cuomo R, Grimaldi L, Massi D, et al. Periocular sebaceous carcinoma: updates in the diagnosis, treatment, staging, and management. International Journal of Dermatology. 2024. doi:10.1111/ijd.17045
BibTeX
@article{Dini2024,
author = {Dini, Federica and Susini, Pietro and Nisi, Giuseppe and Cuomo, Roberto and Grimaldi, Luca and Massi, Daniela and Innocenti, Alessandro and Doni, Laura and Mazzini, Cinzia and Santoro, Nicola and De Giorgi, Vincenzo},
title = {Periocular sebaceous carcinoma: updates in the diagnosis, treatment, staging, and management},
journal = {International Journal of Dermatology},
year = {2024},
doi = {10.1111/ijd.17045}
}
EUVIMED